UNII 70WT22SF4B

SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Unique Ingredient Identifier 70WT22SF4B is listed as a ingredient substance

• RN: 7782-85-6
• NCIT: C61946
• RXCUI: 221090
• PUBCHEM: 6096963
• MF: 2Na.HO4P.7H2O
• INCHI KEY: PYLIXCKOHOHGKQ-UHFFFAOYSA-L
• SMILES: O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O

Dosage Forms

UNII 70WT22SF4B SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE is commonly included in medications in the following forms.

Route	Dosage Form	Potency
AN,INFILTRATION	INJECTION	0.02 %
AURICULAR (OTIC)	SOLUTION	0.5 %
AURICULAR (OTIC)	SUSPENSION	NA
IM - IV	INJECTION	20 %
IM - IV	POWDER	27.93 %
IM - IV	POWDER, FOR INJECTION SOLUTION	8 %
IM - IV	SOLUTION, INJECTION	0.57 %
IM - IV - SC	INJECTION	1.35 MG/ML
IM - SC	INJECTION	0.027 %
IM - SC	POWDER, FOR INJECTION SOLUTION	NA
INTRA-ARTICULAR	INJECTABLE	0.3 %W/W
INTRA-ARTICULAR	INJECTION	ADJPH
INTRA-ARTICULAR	SUSPENSION	0.35 %
INTRABURSAL	INJECTION	1.35 MG/ML
INTRABURSAL	INJECTION	ADJPH
INTRADERMAL	INJECTION	NA
INTRALESIONAL	INJECTABLE	0.14 %
INTRALESIONAL	INJECTION	1.35 MG/ML
INTRALESIONAL	INJECTION, SUSTAINED ACTION	1.35 MG/ML
INTRAMUSCULAR	INJECTABLE	0.3 %W/W
INTRAMUSCULAR	INJECTION	NA
INTRAMUSCULAR	INJECTION, SUSTAINED ACTION	0.067 %W/V
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION	0.54 %
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	21.5 %
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH	0.37 %
INTRAMUSCULAR	SOLUTION, INJECTION	NA
INTRAMUSCULAR	SUSPENSION	0.35 %
INTRASYNOVIAL	INJECTABLE	0.14 %
INTRASYNOVIAL	INJECTION, SUSTAINED ACTION	1.35 MG/ML
INTRAVENOUS	INJECTABLE	14.4 mg/mL
INTRAVENOUS	INJECTABLE	0.094 %
INTRAVENOUS	INJECTION	1.44 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION	2.9 %
INTRAVENOUS	SOLUTION, INJECTION	1.44 %
INTRAVITREAL	INJECTABLE	1.33 %
IV(INFUSION)	INJECTION	1.23 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION	2 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	21.5 %
NASAL	SOLUTION	0.045 %
NASAL	SOLUTION, SPRAY, METERED, PUMP	0.066 %
NASAL	SPRAY, METERED	0.49 %
NERVE BLOCK	INJECTION	0.02 %
OPHTHALMIC	DROPS	0.36 %
OPHTHALMIC	SOLUTION	2.76 mg/1mL
OPHTHALMIC	SOLUTION	2.15 %
OPHTHALMIC	SOLUTION, DROPS	2.5 %
OPHTHALMIC	SOLUTION/DROPS	0.55 %
OPHTHALMIC	SUSPENSION	0.87 %
OPHTHALMIC	SUSPENSION, DROPS	0.43 %
ORAL	CAPSULE	500 MG
ORAL	CAPSULE, SUSTAINED ACTION	92 MG
ORAL	DROPS	NA
ORAL	SOLUTION	70.5 MG/5ML
ORAL	SUSPENSION	62.5 MG/5ML
ORAL	SYRUP	0.65 MG/1ML
ORAL	TABLET	80 MG
ORAL	TABLET, COATED	0.22 MG
ORAL	TABLET, DELAYED ACTION, ENTERIC COATED	16.24 MG
ORAL	TABLET, SUSTAINED ACTION	70 MG
ORAL	TABLET, SUSTAINED ACTION, FILM COATED	105 MG
SOFT TISSUE	INJECTION	ADJPH
SOFT TISSUE	INJECTION, SUSTAINED ACTION	1.35 MG/ML
SUBCUTANEOUS	INJECTABLE	0.19 %
SUBCUTANEOUS	INJECTION	0.38 %
SUBCUTANEOUS	POWDER, FOR INJECTION SOLUTION	0.54 %
SUBCUTANEOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.34 %
SUBCUTANEOUS	SOLUTION, INJECTION	0.089 %
SUBCUTANEOUS	SUSPENSION	0.38 %
SUBCUTANEOUS	SUSPENSION, INJECTION	0.38 %
TOPICAL	CREAM, EMULSION, SUSTAINED RELEASE	0.2 %W/W
TOPICAL	EMULSION, CREAM	0.34 %W/W
TOPICAL	LOTION	1.59 %W/W
TOPICAL	OINTMENT	0.15 %W/W
TOPICAL	SOLUTION	49.78 %W/W
TOPICAL	SOLUTION	2.76 mg/1mL
TOPICAL	SOLUTION, DROPS	0.27 %W/V
TOPICAL	SPONGE	NA
URETHRAL	INJECTION	2 %